03

Sep

Phase III Erectile Dysfunction Clinical Study for Futura MedicalCase

OCT, Eastern Europe’s leading CRO, partners with UK-based Futura Medical completes clinical trial enrollment of 700 patients for MED2002, a topical gel developed to treat erectile dysfunction.

Read

24

Jul

Rituximab biosimilar as first-line treatment for diffuse large B-cell lymphomaCase

A portfolio project for  mAbxience, where OCT Clinical Trials was responsible for all activities in Russia. Rituximab biosimilar as first-line treatment for diffuse large B-cell lymphoma.

Read

11

Apr

Bioequivalence study of a drug for HIV patientsCase

An open-label, randomize, two-period, crossover study in healthy volunteers. Over 90% of volunteers were enrolled during the first two weeks. The target enrollment rates were reached within 21 days

Read